Cleveland Clinic Neurological Institute

Why do hospitalized stroke patients still have worse outcomes despite major advances in stroke care? In this large national analysis, Amre Nouh, MD, MBA, FAHA, FAAN, examines the persistent challenges in in-hospital stroke recognition and treatment, and why separate inpatient-focused protocols may be essential to improving survival and recovery. Read the full article here: https://lnkd.in/eR-QGQyj #CleClinicNeuro #stroke #inpatientcare #neurology #vascularneurology #qualitymetrics

Could CAR T-cell therapy change the future of multiple sclerosis care? In this episode of Neuro Pathways, Jeffrey Cohen, MD, discusses why this emerging approach is drawing so much attention, what early trials are showing, and how it may offer new possibilities for patients whose disease remains difficult to treat. Explore expert insights on immune resetting, safety, patient selection, and where this rapidly evolving field may be headed. Listen here: https://lnkd.in/ehVd8YK6 This activity has been approved for 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵™ and ANCC contact hours. #CleClinicNeuro #multiplesclerosis #mstreatment #CARTcelltherapy #neurology #clinicaltrials

Deep Brain Stimulation continues to play an important role in the management of selected patients with Parkinson's disease, tremor and dystonia. We are proud to see Cleveland Clinic London's neurology and neurosurgery teams expand access to this advanced therapy.

The future of neurological care is taking shape. Every milestone in construction brings us closer to a new space designed to advance patient care, foster collaboration, and support innovation. We're excited to share a glimpse of the progress and look forward to welcoming caregivers, researchers, and patients to this new home of neurological care when it opens in early 2027. #CleClinicNeuro #neurology #neurosurgery #innovationinhealthcare #patientcare #healthcareleadership

Brain death determination remains one of the most definitive — and most challenging — diagnoses in medicine. In this Neuro Pathways podcast, Dr. Dhimant Dani, MD, explains how the updated 2023 guidelines add greater specificity around prerequisites, apnea testing, ancillary testing, and family communication, helping physicians apply a more consistent and accurate approach to BD/DNC. This is an important listen for physicians who want a clearer understanding of what has changed, why EEG is no longer recommended in this setting, and how to navigate a diagnosis that demands both clinical precision and thoughtful communication. 🎧 Listen now: https://lnkd.in/evV72vx4 This activity has been approved for 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵™ and ANCC contact hours. #CleClinicNeuro #neurology #criticalcare #neurocriticalcare #braindeath

At a recent brain health symposium hosted by Cleveland Clinic London, journalist, advocate and founder of WAM at Cleveland Clinic, Maria Shriver shared a powerful message about why brain health deserves greater attention from all of us.   The symposium showcased the latest advances in understanding, diagnosing and treating Alzheimer’s disease in women, while reinforcing the critical role of ongoing research, collaboration and innovation in driving better outcomes for patients and their families. #CleClinicNeuro #WAM #brainhealth #alzheimersdisease

New research from Cleveland Clinic shows that magnetic resonance fingerprinting (MRF) may improve lesion detection in patients with medically refractory epilepsy being evaluated for surgery. In the largest cohort to date, Zhong Irene Wang, PhD, FAES, and colleagues found that MRF added diagnostic value in 46% of presurgical cases, including patients with initially negative conventional MRI. The findings highlight MRF’s potential to reveal subtle epileptogenic abnormalities, better define lesion extent, and support surgical planning in challenging cases. Explore the full article: https://lnkd.in/evjTrJ6s #CleClinicNeuro #epilepsy #epilepsysurgery #neurology #neuroradiology #mri #research #mrfingerprinting

🎓 Congratulations to Our 2026 Adult Neurology Residency Graduates!   We are honored to recognize the remarkable accomplishments of our PGY-4 Neurology Residency Program graduates, whose hard work, empathy, and pursuit of excellence have enriched our program and the care of our patients.   Please join us in celebrating the Class of 2026 and extending our best wishes as they begin the next chapter of their professional journeys:   Eric Aube, MD – Vascular Neurology Fellowship, Cleveland Clinic  Shervin Badihian, MD - Vascular Neurology Fellowship, University of Pennsylvania  Tyler J. Bare, MD - Sleep Medicine Fellowship, Cleveland Clinic  Sakhi Bhansali, MBBS - Epilepsy Fellowship, Cleveland Clinic  Johnny Dang, MD - Neuromuscular Fellowship, Stanford  Jonathan Doan, MD - Vascular Neurology Fellowship, Cleveland Clinic  Sanuri Gunawardena, MD - Movement Disorders Fellowship, Cleveland Clinic  Farah Khan, DO - Headache Fellowship, Loyola  Andrew Lamade, MD, PhD - Neuroimmunology Fellowship, Cleveland Clinic  Elizabeth Page, MD - Neuroimmunology Fellowship, Oregon Health & Science University  Damla Sarisaltik, DO - Vascular Neurology Fellowship, Cleveland Clinic  Emery Weiss, DO - Neuromuscular Fellowship, University of Michigan    We can’t wait to see all that you accomplish!   #CleClinicNeuro #neurology #residency #graduates 

When psychiatric symptoms emerge in a patient with multiple sclerosis, distinguishing primary mental illness from neuroinflammatory or neurodegenerative disease can directly affect diagnosis, treatment, and outcomes. This case study featuring Drew Cumming, MD, offers practical insight into recognizing overlapping neuropsychiatric presentations, avoiding premature diagnostic closure, and understanding why integrated neurologic and psychiatric evaluation matters. Read the article to explore key clinical takeaways and how collaborative care can sharpen clinical decision-making: https://lnkd.in/ejeCFXsE #CleClinicNeuro #multiplesclerosis #neurology #psychiatry #neuropsychiatry #mscare 

What does the future of Alzheimer’s disease treatment look like as biomarkers advance, clinical trials expand, and combination therapies move closer to reality? In Episode 5 of Beyond Diagnosis, a video series developed in partnership with MedPage Today, Jagan A. Pillai, MD, PhD, discusses clinical trial participation, the growing role of biomarkers in earlier diagnosis, and how emerging combination therapies may shape the future of Alzheimer’s care. 🎥 Watch Episode 5: https://lnkd.in/eyw27BA3 #CleClinicNeuro #alzheimersdisease #neurology #brainhealth #physicianeducation